ATE130194T1 - Subkutane verabreichung des humanen choriongonadotropins. - Google Patents

Subkutane verabreichung des humanen choriongonadotropins.

Info

Publication number
ATE130194T1
ATE130194T1 AT87106858T AT87106858T ATE130194T1 AT E130194 T1 ATE130194 T1 AT E130194T1 AT 87106858 T AT87106858 T AT 87106858T AT 87106858 T AT87106858 T AT 87106858T AT E130194 T1 ATE130194 T1 AT E130194T1
Authority
AT
Austria
Prior art keywords
human chorionic
subcutaneous administration
gonadotropine
chorionic gonadotropine
efficaceously
Prior art date
Application number
AT87106858T
Other languages
English (en)
Inventor
Werner Dr Med Saal
Joachim Prof Dr Med Happ
Original Assignee
Serono Pharm Praep
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Pharm Praep filed Critical Serono Pharm Praep
Application granted granted Critical
Publication of ATE130194T1 publication Critical patent/ATE130194T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87106858T 1987-05-12 1987-05-12 Subkutane verabreichung des humanen choriongonadotropins. ATE130194T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87106858A EP0290644B1 (de) 1987-05-12 1987-05-12 Subkutane Verabreichung des humanen Choriongonadotropins

Publications (1)

Publication Number Publication Date
ATE130194T1 true ATE130194T1 (de) 1995-12-15

Family

ID=8196979

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87106858T ATE130194T1 (de) 1987-05-12 1987-05-12 Subkutane verabreichung des humanen choriongonadotropins.

Country Status (6)

Country Link
EP (1) EP0290644B1 (de)
JP (1) JPS6445317A (de)
AT (1) ATE130194T1 (de)
DE (1) DE3751602T2 (de)
ES (1) ES2079345T3 (de)
GR (1) GR3018837T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361992B1 (en) 1996-05-08 2002-03-26 The United States Of America As Represented By The Department Of Health And Human Services Thyroid stimulating hormone superagonists
US10457713B2 (en) 2012-07-30 2019-10-29 Trophogen, Inc. Glycoprotein hormone long-acting superagonists
CA2880520C (en) 2012-07-30 2021-02-09 Trophogen Inc. Glycoprotein hormone long-acting superagonists
US20150065426A1 (en) * 2013-08-27 2015-03-05 Professional Compounding Centers Of America Testosterone Booster Transdermal Compositions
KR20160101906A (ko) 2013-11-05 2016-08-26 트로포젠 인코포레이티드 당단백질 호르몬의 장시간-작용하는 초작용제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608M (fr) * 1963-02-06 1964-06-22 Organon Nv Préparations a action prolongée de gonadotrophines obtenues a partir d'urine.
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
GB2174600B (en) * 1985-05-10 1989-12-20 Univ Melbourne Induction of ovulation in mares

Also Published As

Publication number Publication date
EP0290644A1 (de) 1988-11-17
EP0290644B1 (de) 1995-11-15
ES2079345T3 (es) 1996-01-16
DE3751602T2 (de) 1996-05-02
GR3018837T3 (en) 1996-04-30
DE3751602D1 (de) 1995-12-21
JPS6445317A (en) 1989-02-17

Similar Documents

Publication Publication Date Title
KR890700359A (ko) 안정한 인터페론 복합체
ATE81588T1 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
ATE61523T1 (de) Mittel zur verabreichung von hyaluronsaeure an saeuger.
DE3876052T2 (de) Medizinische verwendung.
FI875533A (fi) Insulinpreparat foer non-parenteral dosering.
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
NO870397D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive organiske platinakomplekser.
ATE240116T1 (de) Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie
ATE130194T1 (de) Subkutane verabreichung des humanen choriongonadotropins.
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
ES2019634B3 (es) Terapia con clorfeniramina.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE3751597D1 (de) Verwendung von 15-Deoxyspergualin als Arzneimittel.
ES2061496T3 (es) Tratamiento intralesional del carcinoma de celulas basales con alfa-interferon humano recombinante.
DK116687A (da) Farmaceutisk praeparat indeholdende aenovantroneae
FI884911A0 (fi) Laekemedel, i dessa saosom aktiva aemnen befintliga fosforin innehaollande 2-isoxazoliner och isoxazoler samt foerfarande foer framstaellning av dessa heterocykliska foereningar.
MX9203339A (es) Tratamiento de enfermedad inflamatoria articular.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
DE3879709D1 (de) Platin-arzneimittel.
IT212642Z2 (it) Perfezionamento del controllore dell'iniezione di gocce medicinali
DK681288A (da) Aenootropt terapeutisk laegemiddelae
KR880014698U (ko) 약탕기용 훨터
DE3786442D1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.
IT1228135B (it) Composizione farmaceutica sterile per la somministrazione per via iniettabile della citidindifosfocolina veicolata tramite i liposomi
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time